description: An adenocarcinoma that arises from the sinonasal tract. It is characterized by the absence of features that resemble intestinal adenocarcinoma.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and lauroyl respectively.


Recurrent Malignant Mastocytosis

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: The reemergence of malignant mastocytosis after a period of remission.


Recurrent Mast Cell Leukemia

description: The reemergence of mast cell leukemia after a period of remission.


Zwitterionic form N-(6-aminohexanoyl)-6-aminohexanoic acid.


name: Creatinine Concentration Greater Than or Equal to 2 mg/dl

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A finding of a creatinine concentration of greater than or equal to 2 mg/dl.


Asp-Phe-Val-Val

A tetrapeptide composed of L-aspartic acid, L-phenylalanine and two L-valine units joined in sequence by peptide linkages.


name: Psychogenic Musculoskeletal Chest Pain with Dysfunctional Breathing

description: A condition in which there is musculoskeletal chest pain associated with inappropriate hyperpnea or tachypnea. (ACC/AHA)


Psychogenic Musculoskeletal Chest Pain

description: A condition in which there is the sensation of musculoskeletal chest pain due to a conversion disorder. (ACC/AHA)


Sellar Gangliocytoma

description: A tumor that arises in the sellar region and is characterized by the presence of mature ganglion cells and neuronal differentiation. It is often associated with the presence of pituitary neuroendocrine tumors/adenomas.


Double-Negative Prostate Carcinoma

description: A metastatic, castration-resistant prostate carcinoma that is composed of fibroblast growth factor-driven malignant cells.


name: Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents

description: Castration-resistant prostate carcinoma which is refractory to second-generation androgen receptor axis-targeted agents, namely abiraterone and enzalutamide.


name: Intermediate Atypical Prostate Carcinoma

description: An aggressive, castration-resistant, histologically distinct, metastatic carcinoma arising from the prostate gland. It is characterized by the presence of a pure population of cytologically bland malignant epithelial cells with moderate to abundant cytoplasm and rare mitotic figures. The prognosis is poor.


Aggressive Variant Prostate Carcinoma

description: A lethal form of advanced castration-resistant prostate carcinoma that emerges in the later stages of castration-resistant treatment. It is an adaptive response to androgen receptor pathway inhibition. The morphologic features vary, ranging from poorly differentiated carcinomas to mixed adenocarcinoma-small cell carcinomas to pure small cell carcinomas expressing neuroendocrine markers. Clinically, it manifests with rapidly progressive disease, visceral or lytic bone metastases and bulky tumor masses. Molecular studies have shown the loss of tumor suppressor genes TP53 and RB1.


Grade 4 Pericardial Effusion, CTCAE

description: Life-threatening consequences; urgent intervention indicated


A synthetic beta-D-glucoside that is a branched pentadecasaccharide derivative consisting of three beta-D-Glc-(1->6)-[alpha-L-Rha-(1->3)]-alpha-D-Glc-(1->3)-alpha-L-Rha2Ac-(1->3)-beta-D-GlcNAc pentasaccharide units linked (1->4) between the GlcNac residue at the reducing end of one unit and the OH at position 4 of the alpha-D-glucose residue of the adjacent unit. An aminoethyl linker from the reducing-end GlcNAc residue allows for efficient conjugation to a carrier protein.


A glycohexaosylceramide having alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc as the glycohexaosyl component.


Advanced Unfavorable Hodgkin Lymphoma

description: An advanced Hodgkin lymphoma with unfavorable prognosis.


tubocapsanolide F

A  withanolide that is 5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione substituted by hydroxy groups at positions 4 and 17 (the 4beta,5beta,6beta,22R stereoisomer). Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.


allylamine antifungal drug

An organonitrogen compound that contains an amino group that is attached to a carbon which is itself attached to an olefinic carbon and which has been used as an antifungal drug.


TERBINAFINE HYDROCHLORIDE

A hydrochloride obtained by reaction of terbinafine with one molar equivalent of hydrogen chloride.


Situs inversus thoracis

description: A congenital condition in which there is complete right-to-left reversal of the position of the thoracic organs.


name: Other Atherosclerosis of Non-Biological Bypass Graft(s) of the Extremities, Bilateral Legs

description: Evidence of other atherosclerosis of non-biological bypass graft(s) of the extremities in both legs not specified elsewhere.


ethyl-dUTP

An organic triphosphate formed by condensation between the gamma-phospho group of 2'-deoxyuridine 5'-triphosphate and ethanol.


Kidney Cancer pT2a TNM Finding v7

description: Kidney cancer with tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney. (from AJCC 7th Ed.)


Kidney Cancer Pathologic TNM Finding v7

description: A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system.  Histologic examination of the surgical specimen and confirmation of the disease extent is required.  (from AJCC 7th Ed.)


Kidney Cancer pT2 TNM Finding v6 and v7

description: Kidney cancer with tumor more than 7 cm in greatest dimension, limited to the kidney. (from AJCC 6th and 7th Eds.)


name: Kidney Cancer Pathologic Regional Lymph Nodes TNM Finding v7

description: A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.  (from AJCC 7th Ed.)


Kidney Cancer pTX TNM Finding v6 and v7

description: Kidney cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)


Kidney Cancer pT0 TNM Finding v6 and v7

description: No evidence of primary tumor. (from AJCC 6th and 7th Eds.)


Kidney Cancer pN0 TNM Finding v6 and v7

description: Kidney cancer with no metastasis to regional lymph nodes. (from AJCC 6th and 7th Eds.)


name: Kidney Cancer pT1a TNM Finding v6 and v7

description: Kidney cancer with tumor 4 cm or less in greatest dimension, limited to the kidney. (from AJCC 6th and 7th Eds.)


Kidney Cancer pT3a TNM Finding v7

description: Kidney cancer with tumor grossly extending into the renal vein or its segmental (muscle containing) branches or tumor invading perirenal and/or renal sinus fat but not beyond Gerota's fascia. (from AJCC 7th Ed.)


Kidney Cancer pM1 TNM Finding v6 and v7

description: Kidney cancer with distant metastasis. (from AJCC 6th and 7th Eds.)


Kidney Cancer pT4 TNM Finding v7

description: Kidney cancer with tumor invading beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland). (from AJCC 7th Ed.)


Kidney Cancer pT3c TNM Finding v7

description: Kidney cancer with tumor grossly extending into the vena cava above the diaphragm, or invading the wall of the vena cava. (from AJCC 7th Ed.)


Kidney Cancer pT3b TNM Finding v7

description: Kidney cancer with tumor grossly extending into the vena cava below the diaphragm. (from AJCC 7th Ed.)


name: Kidney Cancer Pathologic Primary Tumor TNM Finding v7

description: A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of the primary tumor.  (from AJCC 7th Ed.)


Kidney Cancer pT3 TNM Finding v7

description: Kidney cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.)


Kidney Cancer pN1 TNM Finding v7

description: Kidney cancer with metastasis in regional lymph node(s). (from AJCC 7th Ed.)


Kidney Cancer pT1 TNM Finding v6 and v7

description: Kidney cancer with tumor 7 cm or less in greatest dimension, limited to the kidney. (from AJCC 6th and 7th Eds.)


Kidney Cancer pT2b TNM Finding v7

description: Kidney cancer with tumor more than 10 cm in greatest dimension, limited to the kidney. (from AJCC 7th Ed.)


name: Kidney Cancer Pathologic Distant Metastasis TNM Finding v7

description: A pathologic finding about one or more characteristics of kidney cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  There is no pathologic M0 for kidney cancer. (from AJCC 7th Ed.)


name: Kidney Cancer pT1b TNM Finding v6 and v7

description: Kidney cancer with tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. (from AJCC 6th and 7th Eds.)


Kidney Cancer pNX TNM Finding v6 and v7

description: Kidney cancer in which the regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)


thiocyclam hydrochloride

A hydrochloride salt resulting from the formal reaction of equimolar amounts of thiocyclam and hydrogen chloride. A nicotinic acetylcholine receptor agonist used as a broad-spectrum insecticide. Not approved for use within the European Union.


name: Conjunctival Melanoma pT2b TNM Finding v8

description: Conjunctival melanoma with tumor of the nonbulbar conjunctiva with invasion of the substantia propria, more than 2.0 mm in thickness. (from AJCC 8th Ed.)


Urethritis Glandularis

description: A reactive inflammatory disorder affecting the urethra.  It is characterized by the development of small cysts in the urethral wall.  The cysts are lined by metaplastic glandular cells.


Pharyngeal Hemorrhage

description: Bleeding originating from the pharynx.


magnesium oxide nanocrystal

A nanocrystal composed of magnesium oxide.


Grade 4 Stevens-Johnson Syndrome, CTCAE

description: Skin sloughing covering 10-30% BSA with associated signs (e.g., erythema, purpura, epidermal detachment and mucous membrane detachment)


name: Grade 4 Gastrointestinal Stoma Hemorrhage, CTCAE


name: Leiomyosarcoma and Endometrial Stromal Sarcoma cM0 TNM Finding v7

description: No distant metastasis. (from AJCC 7th Ed.)


name: Leiomyosarcoma and Endometrial Stromal Sarcoma Clinical Distant Metastasis TNM Finding v7

description: A clinical finding about one or more characteristics of leiomyosarcoma and endometrial stromal sarcoma, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.  (from AJCC 7th Ed.)


name: Leiomyosarcoma and Endometrial Stromal Sarcoma cM1 TNM Finding v7

description: Distant metastasis (excluding adnexa, pelvic and abdominal tissues). (from AJCC 7th Ed.)


Rheumatoid Nodule, Right Wrist

description: Evidence of rheumatoid nodule in the right wrist.


Decreased Follicles

description: Decreased number and/or size of follicles.


A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoglycerol in which the non-alkylated glycerol moiety has R-configuration.


A member of the class of glycerophosphoglycerols that is sn-glycero-3-phosphoglycerol carrying an unspecified Z-alk-1-enyl substituent at position 1


lysophosphatidylglycerol (P-34:3/0:0)

A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoglycerol in which the alkenyl group contains 34 carbons and has 3 additional double bonds.


name: Oncocytic Variant of Chromophobe Renal Cell Carcinoma

description: A rare variant of chromophobe renal cell carcinoma that exhibits oncocytoma-like features.


name: Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8

description: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the CSF, bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.)


name: Lugano Classification Stage IV Adult Lymphoma AJCC v8


name: Grade 2 Musculoskeletal Deformity, CTCAE

description: Deformity, hypoplasia, or asymmetry able to be remediated by prosthesis (e.g., shoe insert) or covered by clothing


Grade 4 Pelvic Infection, CTCAE

description: Life-threatening consequences; urgent intervention indicated


Pelvic Infection, CTCAE

description: A disorder characterized by an infectious process involving the pelvic cavity.


Grade 3 Pelvic Infection, CTCAE

description: IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated


Grade 2 Pelvic Infection, CTCAE

description: Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)


Grade 5 Pelvic Infection, CTCAE

description: Death


A mannotetrose consisting of four alpha-D-mannopyranose residues linked by three (1->6) glycosidic bonds.


An alpha-D-Galp-(1->3)-D-GalpNAc in which the anomeric centre at the reducing end has beta-configuration.


An inositol phosphomannosylinositol phosphoceramide compound having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and hydroxylation at C-2 and C-3 of the very-long-chain fatty acid.


name: Merkel Cell Carcinoma pN1a TNM Finding v7

description: Merkel cell carcinoma with micrometastasis in regional lymph node(s).  Micrometastases are diagnosed after sentinel or elective lymphadenectomy.  (from AJCC 7th Ed.)


ESOXYBUTYNIN

A 4-(diethylamino)but-2-yn-1-ol yhat has S configuration. In contrast to the (R)- enantiomer, esoxybutynin exhibits essentially no anticholinergic activity.


name: Rheumatoid Polyneuropathy with Rheumatoid Arthritis of Right Shoulder

description: Evidence of rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder.


name: Subglottic Cancer pT0 TNM Finding v6 and v7

description: Subglottic cancer with no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)


A 17-oxo steroid that is 5alpha-androstan-17-one substituted by a beta-hydroxy group at positions 3 and an alpha-hydroxy group at position 7.


name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8

description: Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Grade 3 Middle Ear Intra-Operative Injury, CTCAE


(2E,11R)-11-hydroxydodec-2-enoic acid

An (omega-1)-hydroxy fatty acid that is trans-2-dodecenoic acid in which the 11-pro-R hydrogen is replaced by a hydroxy group.


A purine ribonucleoside 5'-monophosphate having guanine as the nucleobase.


An alkene that is 2-methylhept-1-ene carrying a methyl group at position 4.


GATA1 Gene Mutation Negative

description: A genetic finding indicating that GATA1 gene mutations have not been detected in a sample.


name: systemic lupus erythematosus, susceptibility to, 3


name: Medullary Thyroid Carcinoma pT0 TNM Finding v8

description: No evidence of primary tumor. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma Pathologic TNM Finding v8

description: A pathologic finding about one or more characteristics of medullary thyroid carcinoma, following the rules of the TNM AJCC v8 classification system.


name: Medullary Thyroid Carcinoma Pathologic Regional Lymph Nodes TNM Finding v8

description: A pathologic finding about one or more characteristics of medullary thyroid carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.


name: Medullary Thyroid Carcinoma pM1 TNM Finding v8

description: Distant metastasis. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT2 TNM Finding v8

description: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pN1 TNM Finding v8

description: Metastasis to regional nodes. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT4 TNM Finding v8

description: Advanced disease. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pN1b TNM Finding v8

description: Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes levels I, II, III, IV, or V or retropharyngeal lymph nodes. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT3a TNM Finding v8

description: Tumor measuring 4 cm or more in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT4b TNM Finding v8

description: Very advanced disease; tumor of any size with extension towards the spine or into nearby large blood vessels, invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT1 TNM Finding v8

description: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pN0a TNM Finding v8

description: One or more cytologically or histologically confirmed benign lymph nodes. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT3 TNM Finding v8

description: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pTX TNM Finding v8

description: Primary tumor cannot be assessed. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pN1a TNM Finding v8

description: Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma Pathologic Distant Metastasis TNM Finding v8

description: A pathologic finding about one or more characteristics of medullary thyroid carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.


name: Medullary Thyroid Carcinoma pT1a TNM Finding v8

description: Tumor measuring 1 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT4a TNM Finding v8

description: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pNX TNM Finding v8

description: Regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma pT1b TNM Finding v8

description: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension limited to the thyroid. (from AJCC 8th Ed.)


name: Medullary Thyroid Carcinoma Pathologic Primary Tumor TNM Finding v8

description: A pathologic finding about one or more characteristics of medullary thyroid carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of the primary tumor.


name: Medullary Thyroid Carcinoma pN0 TNM Finding v8

description: No evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)


name: Other Paralytic Syndrome following Other Cerebrovascular Disease Affecting Left Dominant Side

description: Evidence of other paralytic syndrome following other cerebrovascular disease affecting left dominant side not specified elsewhere.


Astrocytoma, Not Otherwise Specified

description: A central nervous system tumor with morphological features of astrocytoma in which there is insufficient information on the IDH genes status.


name: Grade 3 Superficial Soft Tissue Fibrosis, CTCAE

description: Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL


A single-stranded DNA polynucleotide consisting of a repeating unit of thymidine and 5-methyldeoxycytidine residues, with all residues connected by 3'->5' phosphodiester linkages.


Increased Forced Expiratory Volume

description: An increase in the fraction of the forced vital capacity that is exhaled in a specific number of seconds.


name: Grade 1 Anus Mucositis or Stomatitis by Clinical Examination Classification, CTCAE


name: HPV-Mediated (p16-Positive) Oropharyngeal Cancer pNX TNM Finding v8

description: HPV-mediated (p16-positive) oropharyngeal cancer in which the regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)


name: HPV-Mediated (p16-Positive) Oropharyngeal Cancer Pathologic Regional Lymph Nodes TNM Finding v8

description: A pathologic finding about one or more characteristics of HPV-mediated (p16-positive) oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.


name: HPV-Mediated (p16-Positive) Oropharyngeal Cancer pN2 TNM Finding v8

description: HPV-mediated (p16-positive) oropharyngeal cancer with metastasis in more than four lymph nodes. (from AJCC 8th Ed.)


name: HPV-Mediated (p16-Positive) Oropharyngeal Cancer pN1 TNM Finding v8

description: HPV-mediated (p16-positive) oropharyngeal cancer with metastasis in four or fewer lymph nodes. (from AJCC 8th Ed.)


name: HPV-Mediated (p16-Positive) Oropharyngeal Cancer pN0 TNM Finding v8

description: HPV-mediated (p16-positive) oropharyngeal cancer with no metastasis to regional lymph nodes. (from AJCC 8th Ed.)


(2S,3R,11S)-aszonalenin zwitterion

Major microspecies at pH 7.3.


name: Ciliary Body Benign Teratoid Medulloepithelioma

description: A rare, unilateral, benign embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium and contains heterologous elements, particularly cartilage, skeletal muscle, and brain tissue.


Recurrent Extragonadal Seminoma

description: The reemergence of extragonadal seminoma after a period of remission.


name: Recurrent Malignant Extragonadal Germ Cell Tumor

description: The reemergence of malignant extragonadal germ cell tumor after a period of remission.


name: Recurrent Malignant Extragonadal Nongerminomatous Germ Cell Tumor

description: The reemergence of a malignant extragonadal nongerminomatous germ cell tumor after a period of remission.


name: scoliosis, isolated, susceptibility to, 2


Stage IA Cervical Cancer FIGO 2018

description: Invasive cervical carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion less than 5 mm. (FIGO 2018)


Stage IA2 Cervical Cancer FIGO 2018

description: Cervical carcinoma with measured stromal invasion equal or more than 3 mm and less than 5 mm in depth. (FIGO 2018)


Stage IA1 Cervical Cancer FIGO 2018

description: Cervical carcinoma with measured stromal invasion less than 3 mm in depth. (FIGO 2018)


coronene

A ortho- and peri-fused polycyclic arene that consists of six peri-fused benzene rings.


perylene

An ortho- and peri-fused polycyclic arene comprising of five benzene rings that is anthracene in which the d,e and k,l sides are fused to benzene rings.


The D-enantiomer of 4-hydroxyleucine.


A leucine derivative that is leucine substituted by a hydroxy group at position 4.


The L-enantiomer of 4-hydroxyleucine.


name: Major Salivary Gland Cancer pT0 TNM Finding v6 and v7

description: Major salivary gland cancer with no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)


name: 2-amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester


rhosin

A D-tryptophan derivative obtained by formal condensation of the carboxy group of D-tryptophan with the amino group of (quinoxalin-6-yl)methylidenehydrazide. It directly targets the Rho GEF binding domain, thereby preventing Rho from interacting with its GEFs


name: 2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid cyclohexyl ester


quinoxaline pesticide

A quinoxaline derivative that has pesticidal properties.


PROPAQUIZAFOP

A quinoxaline derivative used as systemic herbicide for annual and perennial grasses.


2-methylquinoxaline-6-carboxylic acid

A quinoxaline derivative in which the quinoxaline (1,4-naphthyridine) skeleton is substituted with a carboxy function at C-6 and a methyl group at C-2.


name: 1-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester


PI 3-Kg inhibitor

A quinoxaline derivative  that is quinoxaline in which the hydrogen at position 6 is replaced by a (2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl group. It is a potent inhibitor of the PI3Kgamma, with an IC50 of 8 nM and inhibits the progression of joint inflammation and damage in both lymphocyte-independent and dependent mouse models of rheumatoid arthritis.


QUIZALOFOP-P-ETHYL

An ethyl 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate that has R configuration. A proherbicide for quizalofop-P, it is used to control annual and perennial grass weeds in a variety of crops, including potatoes, sugar beet, peanuts, cotton and flax.


name: 3-(4-butyl-3-oxo-2-quinoxalinyl)propanoic acid [2-(3-chloro-4-fluoroanilino)-2-oxoethyl] ester


name: 3-pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester


A hydroxyquinoxaline that consists of quinoxaline having a single hydroxy substituent located at position 2.


name: N-[(1-hydroxy-4-oxido-2-quinoxalin-4-iumylidene)methylimino]carbamic acid methyl ester


(S)-quizalofop

A 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid that has S configuration. It is the (inactive) enantiomer of the herbicide quizalofop-P.


name: 4-chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester


(+)-cyclazosin

A monocarboxylic acid amide obtained by formal condensation of the carboxy group of furoic acid with the secondary amino group of 6,7-dimethoxy-2-[(4aR,8aS)-octahydroquinoxalin-1-yl]quinazolin-4-amine.


name: 4-[[[2,3-bis(2-pyridinyl)-6-quinoxalinyl]amino]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester


name: 2-(3-oxo-4H-quinoxalin-2-yl)propanoic acid ethyl ester


A quinoxaline derivative in which quinoxalin-2(1H)-one carries an L-serine-based function {[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino}-3-oxopropyl} at C-2. One of a series of mucosal-associated invariant T (MAIT) cell agonists.


CGP 78608

A phosphonic acid in which the hydrogen attached to phosphorous is substituted by a 1-{[(7-bromo-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)methyl]amino}ethyl group. Potent and selective NMDA antagonist that acts through the glycine site (IC50 = 5 nM). Displays >500-fold selectivity over kainate and AMPA receptors (IC50 values are 2.7 and 3 muM respectively). Anticonvulsant in vivo following systemic administration.


(S)-quizalofop-ethyl

An ethyl 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate that has S configuration.


name: 5-[[1-oxo-3-(3-oxo-4H-quinoxalin-2-yl)propoxy]methyl]-2-furancarboxylic acid ethyl ester


name: 4-[[3-[(4-chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester


quinoxaline antifungal agent

A compound that has significant antifungal properties whose structure contains a quinoxaline moiety.


quizalofop-P-tefuryl

A tetrahydrofurylmethyl ester resulting from the formyl condensation of the carboxy group of quizalofop-P with the hydroxy group of tetrahydrofurfuryl alcohol.


name: 4-(2-quinoxalinylamino)benzoic acid ethyl ester


name: 6-quinoxalinecarboxylic acid phenyl ester


A quinoxaline derivative in which the quinoxaline (1,4-naphthyridine) skeleton is substituted with a methyl group at each of positions C-2 and C-3.


A quinoxaline derivative in which the quinoxaline (1,4-naphthyridine) skeleton is substituted at C-2 with a methyl group.


name: 2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl ester


A quinoxaline derivative in which the quinoxaline (1,4-naphthyridine) skeleton is substituted at C-5 with a methyl group.


name: 2-amino-1-cyclohexyl-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester


quizalofop-P

A 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid that has R configuration. An acetyl-CoA carboxylase inhibitor, it is used (generally as the corresponding ethyl or tefuryl ester proherbicides) for the control of annual and perennial grass weeds in sugar beet.


name: 2,3-dimethyl-6-quinoxalinecarboxylic acid (2-bromophenyl)methyl ester


quinoxaline herbicide

A quinoxaline pesticide that has herbicidal activity.


grazoprevir

An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.


voxtalisib

A sulfonamide obtained by formal condensation of the sulfonic acid group of 4-[(3-methoxy-4-methylbenzoyl)amino]benzenesulfonic acid with the primary aromatic amino group of N-(3,5-dimethoxyphenyl)quinoxaline-2,3-diamine. A dual PI3K/mTOR inhibitor used in cancer treatment.


name: Grade 3 Vagina Stricture or Stenosis, CTCAE


An androstanoid that is 5alpha-dihydrotestosterone carrying an additional hydroxy susbstituent at position 19.


name: Stage I Pancreatic Neuroendocrine Tumor AJCC v8

description: Stage I includes: T1, N0, M0. T1: Tumor limited to the pancreas and measuring less than 2 cm. N0: No regional lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.)


name: Drug or Chemical Induced Diabetes Mellitus with Mild Non-Proliferative Diabetic Retinopathy with Macular Edema, Right Eye

description: Evidence of drug or chemical induced diabetes mellitus with mild non-proliferative diabetic retinopathy with macular edema in the right eye.


RILPIVIRINE HYDROCHLORIDE

A hydrochloride obtained by reaction of rilpivirine with one equivalent of hydrochloric acid. Used for treatment of HIV.


Infiltrating Intramuscular Lipoma

description: An infiltrating lipoma that affects skeletal muscle.  It has a higher rate of local recurrence.


name: PSA Level Greater than One Hundred Fifty

description: A blood concentration of prostate specific antigen greater than 150 ng/mL.


name: Refractory Endometrial Dedifferentiated Carcinoma

description: Endometrial dedifferentiated carcinoma that is resistant to treatment.


Campylobacter jejuni infection

description: An infection that is caused by Campylobacter jejuni.


Small Intestinal Infection

description: An infectious process affecting the small intestine.


Duodenal Infection

description: An infectious process affecting the duodenum.


A C-glycosyl compound that is luteolin substituted by beta-D-glucopyranosyl moieties at positions 6 and 8 respectively.


(1R,2R,5S)-AH23848 hemicalcium salt

An organic calcium salt that is the hemicalcium salt of (1R,2R,5S)-AH23848.


fenoprofen calcium (anhydrous)

The anhydrous form of the calcium salt of fenprofen. The dihydrate form is used as a non-steroidal anti-inflammatory drug for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis.


prohexadione-calcium

A calcium salt containing equal numbers of prohexadione(2-) and Ca(2+) ions. A plant growth regulator, it is used as an anti-lodging agent in small-grain cereals.


PITAVASTATIN CALCIUM

The calcium salt of pitavastatin. Used for treatment of hypercholesterolemia (elevated levels of cholesterol in the blood) on patients unable to sufficiently lower their cholesterol levels by diet and exercise.


calcium carbimide

The calcium salt of cyanamide, formed when calcium carbide reacts with nitrogen


MUPIROCIN CALCIUM

The anhydrous form of the calcium salt of mupirocin. The dihydrate form is used as an antibacterial drug for the treatment of skin infections.


calcium glucoheptonate

The calcium salt of (2xi)-D-gluco-heptonic acid. It is used as a calcium supplement for treatment of hypocalcaemia.


calcium nitrate tetrahydrate

A hydrate that is the tetrahydrate form of calcium nitrate.


LONAZOLAC CALCIUM

An organic calcium salt having [3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetate as the counterion.


bumadizone calcium

An organic calcium salt having 2-[(1,2-diphenylhydrazino)carbonyl]hexanoate as the counterion. Used (as its hemihydrate) for treatment of rheumatoid arthritis.


calcium citrate

An organic calcium salt composed of calcium cations and citrate anions in a 3:2 ratio.


calcium chloride hexahydrate

A hydrate that is the hexahydrate form of calcium chloride.


CALCIUM STEARATE

An organic calcium salt of stearic acid. It is a component of some lubricants and surfactants.


calcium acetate

The calcium salt of acetic acid. It is used, commonly as a hydrate, to treat hyperphosphataemia (excess phosphate in the blood) in patients with kidney disease: the calcium ion combines with dietary phosphate to form (insoluble) calcium phosphate, which is excreted in the faeces.


calcium chloride dihydrate

A hydrate that is the dihydrate form of calcium chloride.


(1S,2S,5R)-AH23848 hemicalcium salt

An organic calcium salt that is the hemicalcium salt of (1S,2S,5R)-AH23848.


calcium glycerylphosphate

An organic calcium salt having glycerol 2-phosphate(2-) as the counterion.


calcium titanate

A calcium salt with the formula CaTiO3, generally obtained in the form of the mineral perovskite.


ATORVASTATIN CALCIUM

An organic calcium salt composed of calcium cations and atorvastatin anions in a 1:2 ratio.


EDTA monocalcium salt

An organic calcium salt that is the monocalcium salt of ethylenediaminetetraacetic acid (EDTA).


LEVOMEFOLATE CALCIUM

An organic calcium salt of (6S)-5-methyltetrahydrofolic acid.


calcium nitrate

Inorganic nitrate salt of calcium.


Stage IVB Rectal Cancer AJCC v8

description: Stage IVB includes: Any T, Any N, M1b. M1b: Metastasis to two or more sites or organs without peritoneal metastasis.  (AJCC 8th ed.)


hexose phosphate

A phospho sugar that is formally obtained from a hexose.


fructose 6-phosphate

A ketohexose monophosphate consisting of fructose having a phosphate group located at the 6-position.


L-sorbose 1-phosphate

The L-stereoisomer of sorbose 1-phosphate.


D-tagatofuranose 1,6-bisphosphate

The furanose form of D-tagatose 1,6-bisphosphate.


beta-D-fructofuranose 2-phosphate

The beta-anomer of D-fructofuranose 2-phosphate.


D-aldohexose 6-phosphate

Any D-aldose having a six-carbon chain with a phosphate group at C-6.


A hexose phosphate that is alpha-D-mannose phosphorylated on O-2 and O-4.


D-allose 6-phosphate

An allose phosphate consisting of D-allose having a monophosphate group at the 6-position.


D-fructose 6-phosphate

A ketohexose monophosphate that is D-fructose having a phosphate substituent at position 6. It is an important intermediate in the carbohydrate metabolism.


D-galactopyranose 1-phosphate

A D-galactose phosphate that consists of  D-galactopyranose having a single phospho substituent located at the 1-position. It is an intermediate obtained during the the galactose metabolism.


D-tagatopyranose 1-phosphate

A ketohexose monophosphate that is D-tagatopyranose in which the phosphono substituent is located at position 1.


beta-D-fructofuranose 2,6-bisphosphate

A D-fructofuranose 2,6-bisphosphate with a beta-configuration at the anomeric centre.


A mannose phosphate in which in which the phosphate group of alpha-D-mannose 1-phosphate is esterified by the alcoholic hydroxy group of L-serine.


2-deoxy-D-glucopyranose 6-phosphate

A D-hexopyranose 6-phosphate that is the 6-monophospho derivative of 2-deoxy-D-glucopyranose.


L-fuculose 1-phosphate

The 1-O-phospho derivative of L-fuculose.


D-hexose phosphate

Any mono-phosphorylated D-hexose having a chain of six carbon atoms in the molecule.


beta-D-mannosyl C30-phosphomycoketide

A mannose phosphate consisting of beta-D-mannose having a (4S,8S,12S,16S,20S)-4,8,12,16,20-pentamethylpentacosyl)phosphate group at position 1.


beta-D-mannosyl C32-phosphomycoketide

A mannose phosphate consisting of beta-D-mannose having a (4S,8S,12S,16S,20S)-4,8,12,16,20-pentamethylheptacosyl)phosphate group at position 1.


tagatose 6-phosphate

A  ketohexose monophosphate that is tagatose attached to a phosphate group at position 6.


D-fructose 1,6-bisphosphate

A ketohexose bisphosphate that is D-fructose substituted by phosphate groups at positions 1 and 6. It is an intermediate in the glycolysis metabolic pathway.


alpha-D-glucose 1,6-bisphosphate

A D-glucose 1,6-bisphosphate in which both phosphate groups are monophosphates.


L-rhamnulose 1-phosphate

A deoxyketohexose phosphate consisting of L-rhamnulose having a monophosphate group at the 1-position.


D-galactopyranose 6-phosphate

The pyranose form of D-galactose 6-phosphate.


beta-D-mannose 6-phosphate

A D-mannopyranose 6-phosphate with a beta-configuration at the anomeric position.


A ketohexose monophosphate having keto groups at the 2- and 5-positions, hydroxy groups at the 3- and 4-positions and the phosphate group at the 6-position.


beta-D-tagatofuranose 6-phosphate

A D-tagatofuranose 6-phosphate with a beta-configuration at the anomeric position.


alpha-D-glucose 6-phosphate

A D-glucopyranose 6-phosphate where alpha-D-glucose is the sugar component.


beta-D-glucose 6-phosphate

A D-glucopyranose 6-phosphate in which the anomeric centre has beta-configuration.


aldehydo-D-galactose 6-phosphate

The ring-opened aldehydo-form of D-galactose 6-phosphate.


alpha-D-hexose 1-phosphate

Any hexose-1-phosphate which has D configuration at position 5 and alpha-configuration at the anomeric centre.


D-mannose 6-phosphate

A mannose phosphate in which the phosphate group is attached to position 6.


D-mannose 1-phosphate

A mannose phosphate that is D-mannose carrying a phosphate group at position 1.


D-fructofuranose 1-phosphate

The furanose form of D-fructose 1-phosphate.


The alpha-anomer of D-mannose 6-phosphate.


D-glucose 6-phosphate

A D-glucose monophosphate in which the phosphate group is attached to position 6.


A fully saturated D-mannose polyisoprenoid phosphoglycolipid (C32 chain-length) obtained from Mycobacterium tuberculosis.


D-fructofuranose 2,6-bisphosphate

A ketohexose bisphosphate that is D-fructofuranose carrying phosphate groups at positions 2 and 6.


alpha-D-tagatofuranose 6-phosphate

A D-tagatofuranose 6-phosphate with an alpha-configuration at the anomeric position.


alpha-D-mannose 1-phosphate

A D-mannose 1-phosphate with an alpha-configuration at the anomeric position.


D-fructose 1-phosphate

The D-enantiomer of fructose 1-phosphate.


A fully saturated beta-D-mannose polyisoprenoid phosphoglycolipid (C27 chain-length) obtained from Mycobacterium tuberculosis.


keto-D-fructose 1,6-bisphosphate

A ketohexose bisphosphate that is D-fructose substituted by phosphate groups at positions 1 and 6.


keto-D-fructose 1-phosphate

The open chain form of D-fructose 1-phosphate.


2-deoxy-D-glucose 6-phosphate

A deoxyaldohexose phosphate comprising 2-deoxy-D-glucose having the phosphate group at the 6-position.


D-psicose 6-phosphate

A ketohexose monophosphate consisting of D-psicose having a phosphate group located at the 6-position.


A mannose phosphate that is D-mannose phosphorylated at position 6 by a N-acetyl-D-glucosaminyl-1-phosphono group. Found in the milk of giant pandas.


D-mannopyranose 6-phosphate

The pyranose form of D-mannose 6-phosphate.


A D-glucopyranose 1-phosphate in which the anomeric centre has alpha-configuration.


L-tagatofuranose 6-phosphate

The furanose form of L-tagatose 6-phosphate.


fructose 1-phosphate

A ketohexose monophosphate consisting of fructose having a phosphate group located at the 1-position


FRUCTOSE 1,6-DIPHOSPHATE

A D-fructofuranose 1,6-bisphosphate with an alpha-configuration at the anomeric position.


beta-D-glucose 1-phosphate

The beta-anomer of D-glucose 1-phosphate.


beta-L-fucose 1-phosphate

The beta-anomer of L-fucose 1-phosphate.


A mannose phosphate consisting of beta-D-mannose having a (4S,8S,12S,16S,20S)-4,8,12,16,20-pentamethylheptacosyl)phosphono(difluoro)methyl group at position 1.


D-tagatofuranose 6-phosphate

The furanose form of D-tagatose 6-phosphate.


D-tagatose 1,6-bisphosphate

A ketohexose bisphosphate that is D-tagatose carrying phosphate groups at positions 1 and 6.


A mannose phosphate consisting of beta-D-mannose having a (4S)-4-methylheptacosyl)phosphate group at position 1. Synthetic analogue of beta-D-mannosyl C32-phosphomycoketide.


A D-galactose 6-phosphate that is beta-D-galactofuranose in which the hydroxy group at position 6 has been converted into the corresponding dihydrogen phosphate derivative.


keto-D-tagatose 6-phosphate

A D-tagatose 6-phosphate that is in the open-chain keto-form.


A mannose phosphate consisting of beta-D-mannose having a (4S,8S,12S,16S,20S)-4,8,12,16,20-pentamethylheptacosyl)phosphonomethyl group at position 1.


alpha-D-mannosyl phosphomycoketide

A mannose phosphate consisting of alpha-D-mannose having a (4S,8S,12S,16S,20S)-4,8,12,16,20-pentamethylheptacosyl)phosphate group at position 1.


glucose 6-phosphate

A glucopyranose ring with a phosphate replacing the hydroxy in the hydroxymethyl group at position 6.


keto-L-tagatose 6-phosphate

The open chain form of L-tagatose 6-phosphate


D-hexopyranose 6-phosphate

Any D-hexose 6-phosphate in which the hexose is in the pyranose form.


A galactose phosphate that is 4-nitrophenyl beta-D-galactoside substituted at position 6 by a monophosphate group.


beta-D-fructofuranose 1-phosphate

A D-fructofuranose 1-phosphate in which the anomeric centre has beta-configuration.


keto-D-fructose 6-phosphate

The open chain form of D-fructose 6-phosphate.


A ketohexose monophosphate that is 3-dehydro-D-glucose having the monophosphate group located at position 6.


D-glucopyranose 1-phosphate

A D-glucose monophosphate in which the phosphate group is located at position 1.


FOSFRUCTOSE

The furanose form of D-fructose 1,6-bisphosphate.


Effective Regurgitant Orifice Area

description: The quantitative measurement of the effective regurgitant orifice area of a cardiac valve.


A glycohexaosylceramide having N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl component attached to the primary hydroxy function of a ceramide with d18:0 sphingoid base and undefined fatty acyl chain.


name: Cervical Mucinous Adenocarcinoma, Not Otherwise Specified

description: A cervical mucinous adenocarcinoma in which more than 50% of malignant cells contain intracytoplasmic mucin. There is no evidence of gastric, intestinal, or signet ring cell differentiation.


A derivative of toluene bearing an additional ethyl substituent at position 3.


Localized PRETEX IV Hepatoblastoma

description: PRETEX IV hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Ala-Val zwitterion

A dipeptide zwitterion resulting from the transfer of a proton from the carboxy to the amino group of Ala-Val; major species at pH 7.3.


hexan-3-yl benzoate

Hexan-3-yl ester of benzoate.


glycerolipid

Any member of the group of lipids containing a common glycerol backbone to which at least one fatty acid-derived group is attached.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituent both at positions 1 and 2 is specified as (9Z)-octadecenoyl respectively.


A 1-acyl-sn-glycerol that is the S-enantiomer of 2,3-dihydroxypropyl decanoate.


A triacyl-sn-glycerol in which the 1-acyl group is tetradecanoyl while the 2- and 3-acyl groups are oleoyl.


A 1-monolysocardiolipin in which the remaining phosphatidyl acyl groups at positions 1, 2 and 2' are specified as linoleoyl.


A triacylglycerol 62:13 in which the acyl group at position 1 is specified as octadecenoyl while those at positions 2 and 3 are both docosahexaenoyl groups.


triacylglycerol 42:0

A triglyceride in which the three acyl groups contain a total of 42 carbons and 0 double bonds.


phosphatidylserine 40:0

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 0 double bonds.


A glycerophosphoethanolamine that is sn-glycero-3-phosphoethanolamine bearing a single alk-1-enyl substituent at an unspecified position.


A monoglyceride in which the acyl substituent is located at position 1.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are both specified as hexanoyl.


GLYCERYL MONOLINOLEATE

A 1-acyl-sn-glycerol that is the S-enantiomer of 1-monolinolein.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as decanoyl


glycerophosphoglycerol

A glycerophosphoglycerol where both glycerol moieties are attached at primary positions.


An N-acyl-O-(3-sn-phosphatidyl)-L-serine obtained by formal condensation of the carboxy group of hexadecanoic acid with the amino group of 1-octadecanoyl-2-oleoyl-sn-glycero-3-phospho-L-serine.


phosphatidylinositol 34:1

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 34 carbon atoms and 1 double bond.


triacylglycerol 52:1

A triglyceride in which the three acyl groups contain a total of 52 carbons and 1 double bond.


A 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol compound having an undefined acyl substituent in an unspecified position on the inositol ring.


A glycerol compound having an alk-1-enyl substituent in the 1-position


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both acyl substituents are specified as (9Z)-hexadecenoyl (palmitoleoyl).


phosphatidylethanolamine (18:1/22:4)

A phosphatidylethanolamine in which one acyl group has 18 carbons and 1 double bond while the other has 22 carbons and 4 double bonds.


A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as lauroyl (dodecanoyl).


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (13Z,16Z)-docosadienoyl and linoleoyl respectively.


A 1-alkyl-2-acyl-sn-glycerol 3-phosphate in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and acetyl respectively.


A 3-sn-glycerophosphoserine compound having acyl substituents at the 1- and 2-hydroxy positions.


1-lauroyl-sn-glycerol 3-phosphate

A 1-acyl-sn-glycerol 3-phosphate having lauroyl (dodecanoyl) as the 1-O-acyl group.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecanoyl and octadecadienoyl respectively.


TRIPALMITIN

A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by palmitic (hexadecanoic) acid.


phosphatidylethanolamine 33:1

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the two acyl groups contain a total of 33 carbons and 1 double bond.


phosphatidylglycerol 36:1

A phosphatidylglycerol in which the two acyl groups contain 36 carbon atoms and 1 double bond.


An N-acyllysophosphatidylethanolamine in which the N-acyl group is specified as icosanoyl while the phosphatidyl acyl group is specified as oleoyl; major species at pH 7.3.


A glycerolipid where one of the acyl groups is specified as (9Z,12Z,15Z)-octadeca-9,12,15-trien-6-ynoyl


A glycerolipid where one of the acyl groups is specified as (9Z,11E,13E)-octadecatrienoyl.


lysophosphatidylinositol 20:3

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 20 carbons and 3 double bonds.


monoacylglycerol 16:0

A monoglyceride in which the acyl group contains a total of 16 carbon atoms and 0 double bond.


A phosphoethanolamine-glycosyl-phosphatidylinositol derivative where R1 can be an alkyl or an acyl group, R2 and R3 are both acyl groups of undefined composition.


phosphatidylserine 38:1

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 38 carbon atoms and 1 double bond.


A glycerolipid where one of the acyl groups is specified as (9Z,11E,13Z)-octadeca-9,11,13-trienoyl.


phosphatidylethanolamine 36:0

A phosphatidylethanolamine in which the two acyl groups contain a total of 36 carbons and no double bonds.


1-alpha-linolenoyl 2-acylglycerolipid

Any glycerolipid where the 1-acyl group is specified as alpha-linolenoyl.


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as decanoyl.


A galactosylglycerolipid with an alkyl group at the sn-1 position, an acyl group at the sn-2 position and a beta-D-galactosyl residue at the sn-3 position.


phosphatidylglycerol 16:0/18:1

A phosphatidylglycerol 34:1 in which the acyl group at position 1 contains 16 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and (6Z)-octadecenoyl respectively.


A triacylglycerol 56:3 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl, while that at position 3 is icosatrienoyl.


phosphatidylinositol phosphate

Any member of the phosphoinositide family of compounds, of which seven occur naturally.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and (9Z)-octadecenoyl respectively; major species at pH 7.3.


A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as hexadecanoyl (palmitoyl).


A phosphatidylethanolamine in which the phosphatidyl acyl group at C-1 and C-2 is stearoyl.


A 1-acyl-2-arachidonoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as stearoyl (octadecanoyl).


A glycerophosphoinositol resulting from partial hydrolysis of a phosphatidyl-1D-myo-inositol, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as stearoyl and linoleoyl respectively.


lysophosphatidylglycerol 18:1

A lysophosphatidylglycerol in which the acyl group (position of attachment not specified) contains 18 carbons and 1 double bond


dilauroyl phosphatidylglycerol

A phosphatidylglycerol in which the phosphatidyl acyl groups are both lauroyl.


lysophosphatidylethanolamine (18:2/0:0)

A lysophosphatidylethanolamine 18:2 in which the acyl group is located at position 1.


A phosphatidylinositol 38:3 in which one acyl group has 18 carbons and is fully saturated while the other has 20 carbons and 3 double bonds (position not specified).


monoradylglycerol

Any lipid that is glycerol bearing a single acyl, alkyl or alk-1-enyl substituent at an unspecified position.


lysobisphosphatidic acid

A lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and stearoyl respectively.


A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are oleoyl and 6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl respectively.


An optically active form of phosphatidylethanolamine having R-configuration.


lysophosphatidylethanolamine 20:3

An acyl-sn-glycero-3-phosphoethanolamine in which the acyl group contains twenty carbons with three double bonds and is attached to the glycero moiety at either position 1 or 2.


A glycerolipid where one of the acyl groups is specified as (5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl.


A 1-phosphatidyl-1D-myo-inositol 3-phosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


An anionic lysophospholipid obtained by deprotonation of the carboxy and phosphate groups of 1-acyl-2-hydroxy-sn-glycero-3-phospho-(N-acyl)-L-serine; major species at pH 7.3.


tetraoctadec-11-enoyl cardiolipin

A cardiolipin in which all four of the phosphatidyl acyl groups are specified as octadec-11-enoyl.


phosphatidylserine 38:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 38 carbon atoms and 2 double bonds.


phosphatidylethanolamine (16:1/16:1)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both acyl groups contain 16 carbons and 1 double bond.


lysophosphatidylserine 20:0

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 0 double bonds.


phosphatidylethanolamine (16:0/20:4)

A phosphatidylethanolamine 36:4 in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 20 carbons and 4 double bonds.


A 1-O-(alk-1-enyl)-2-octanoyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl group has Z geochemistry.


A 1-phosphatidyl-1D-myo-inositol in which the 1- and 2-acyl groups are octadecanoyl and octadecadienoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as octadecanoyl (stearoyl) and (5E,8E,11E,14E)-eicosatetraenoyl respectively.


A phosphatidylethanolamine 38:4 in which one acyl group has 18 carbons and is fully saturated while the other has 20 carbons and 4 double bonds (position not specified).


A 2-monoglyceride obtained by formal condensation of the carboxy group of 14,15-EET with the 2-hydroxy group of glycerol.


phosphatidylglycerol 36:0

A phosphatidylglycerol in which the two acyl groups contain 36 carbon atoms and no double bonds


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as myristoyl (tetradecanoyl).


A triacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specifed as linoleoyl.


lysophosphatidylglycerol 18:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C18 chain and is attached to the glycero moiety at either position 1 or 2.


phosphatidylserine 40:5

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 5 double bonds.


phosphatidylethanol

A glycerophospholipid that is the monoethyl ester of any phosphatidic acid.


An N-acyllysophosphatidylethanolamine in which the N-acyl group is specified as stearoyl (octadecanoyl) while the phosphatidyl acyl group is specified as oleoyl (9Z-octadecenoyl)


A class of glycerophospholipids in which a (2S)-2,3-diacylglycerol phosphate group is esterified by condensation with the alcoholic hydroxy group of L-serine.


phosphatidylglycerol 34:3

A phosphatidylglycerol in which the two acyl groups contain 34 carbon atoms and 3 double bonds.


phosphatidylglycerol 35:1

A phosphatidylglycerol in which the two acyl groups contain a total of 35 carbon atoms and 1 double bond.


phosphatidylethanolamine (18:0/20:2)

A phosphatidylethanolamine in which one acyl group has 18 carbons and is fully saturated while the other has 20 carbons and 2 double bonds.


phosphatidylethanolamine (16:0/18:2)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 18 carbons and 2 double bonds.


A phosphatidylinositol bisphosphate in which the two phosphate groups are at C-4 and C-5 of the inositol moiety which has the 1D-myo configuration.


A triglyceride where at least one of R1, R2 or R3 is a linoleoyl group. Formula is C23H36O6R2


tetrahexadecanoyl cardiolipin

A cardiolipin in which all four of the phosphatidyl acyl groups are specified as hexadecanoyl (pamitoyl).


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as linoleoyl and oleoyl respectively.


An N-acylphosphatidylethanolamine in which the N- and O-acyl groups are specified as hexadecanoyl (palmitoyl).


A 1,2-diacyl-sn-glycero-3-phosphate in which the acyl groups at positions 1 and 2 are specified as octanoyl.


phosphatidylglycerol 18:3/16:1

A phosphatidylglycerol 36:1 in which the acyl group at position 1 contains 18 carbons and 3 double bonds while that at position 2 contains 16 carbons and 1 double bond.


A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the Z-alk-1-enyl group is specified as (1Z)-octadec-1-enyl.


N-acyllysophosphatidyl-L-serine

An acylglycerophosphoserine obtained by formal condensation of the carboxy group of any carboxylic acid with the amino group of any lysophosphatidyl-L-serine.


phosphatidylethanolamine 40:1

A phosphatidylethanolamine in which the two acyl groups contain 40 carbon atoms and 1 double bond.


A triacylglycerol 53:2 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecenoyl and nonadecenoyl respectively.


A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are palmitoyl and stearoyl respectively.


phosphatidylglycerol O-34:4

An alkyl,acyl-sn-glycero-3-phosphoglycerol in which the alkyl or acyl groups at positions 1 and 2 contain a total of 34 carbons and 4 double bonds.


A glycerol-1-phosphate compound having an alk-1-enyl substituent at the 3-position.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and oleoyl.


phosphatidylserine (17:1/18:1)

A phosphatidylserine 35:2 in which the acyl group at C-1 contains 17 carbons and 1 double bind while that at C-2 contains 18 carbons and 1 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as oleoyl and myristoyl respectively.


A triacylglycerol 62:13 in which the acyl groups at positions 1 and 2 are specified as octadecadienoyl while that at position 3 is a docosahexaenoyl group.


A glycerophosphoethanolamine that is sn-glycero-3-phosphoethanolamine carrying any alkyl substituent at position 1.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as hexadecanoyl (palmitoyl).


palmitoleoyl-containing glycerolipid

A glycerolipid where one of the acyl groups is specified as palmitoleoyl.


A 1-acyl-sn-glycerol in which the acyl group is specified as oleoyl.


monoacylglycerol 22:5

A monoglyceride in which the acyl groups contain a total of 22 carbons and 5 double bonds.


A triglyceride having stearoyl (octadecanoyl) groups at positions 1 and 3 and a palmitoyl (hexadecanoyl) group at position 2. It is a metabolite of the nematode Caenorhabditis elegans.


A CDP-diacylglycerol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecenoyl groups.


glycerophosphomethanol

The glycerol phosphate ester of a phosphomethanol.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and palmitoyl respectively.


phosphatidylethanolamine (17:1/17:1)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both acyl groups contain 17 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as palmitoyl (hexadecanoyl).


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphate in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and oleoyl respectively.


A CDP-diacylglycerol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as myristoyl and oleoyl respectively.


A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as arachidonoyl.


A triacylglycerol 52:6 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecenoyl, octadecadienoyl and octadecatrienoyl respectively.


phosphatidylinositol (18:1/18:2)

A phosphatidylinositol 36:3 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 18 carbons and 2 double bonds


phosphatidylethanolamine (18:0/20:3)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 20 carbons and 3 double bonds.


A 1-phosphatidyl-1D-myo-inositol in which both phosphatidyl acyl groups are specified as linoleoyl.


phosphatidylserine 18:0

A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups contain a total of 18 carbons and are fully saturated.


A member of the class of glycerophosphoglycerols obtained by formal condensation  of the carboxy group of oleic acid with one of the primary hydroxy groups of (S,S)-glycero-1-phospho-1'-glycerol


A glycerolipid where one of the acyl groups is specified as (7Z,10Z)-hexadecadienoyl.


A triacylglycerol 46:0 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecanoyl and dodecanoyl respectively.


ditetradecanoyl phosphatidylglycerol

A phosphatidylglycerol in which the phosphatidyl acyl groups are both tetradecanoyl (myristoyl).


phosphatidylethanolamine (24:0/18:1)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 24 carbons and no double bonds while that at C-2 contains 18 carbons and 1 double bond.


triacylglycerol 64:16

A triglyceride in which the three acyl groups contain a total of 64 carbons and 16 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl and icosanoyl respectively.


1-lysophosphatidic acid

Any member of the class of lysophosphatidic acids which has a free hydroxy group at the 1-position of the glycerol moiety.


An ether lipid consisting of glycerol substituted at position 2 by an acetyl group and at position 1 by an unspecified alkyl group.


phosphatidylserine 40:4

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 4 double bonds.


tetralinoleoyl cardiolipin

A cardiolipin in which all four phosphatidyl acyl groups are specified as linoleoyl.


A 2-monoglyceride obtained by formal condensation of the carboxy group of 11,12-epoxy-(5Z,8Z,14Z)-icosatrienoic acid with the 2-hydroxy group of glycerol.


Any glycerolipid in which the acyl group at position 2 of the glycerol moiety is specified as palmitoyl.


A 1,2-diacyl-sn-glycero-3-phosphate in which the acyl groups at positions 1 and 2 are specified as hexanoyl.


A phosphatidylinositol mannoside having the phosphatidyl moiety (with specific O-acyl groups) at the 1-position, a single mannosyl residue at the 2-position and a linear pentamannoside at position 6 of the inositol ring.


A lysophosphatidylethanolamine 22:4 in which the acyl group is located at position 1.


triacylglycerol 46:1

A triglyceride in which the three acyl groups contain a total of 46 carbons and 1 double bond.


A monosubstituted glycerol having an alk-1-enyl substituent located at the sn-1 or sn-3 position. The orientation of the alk-1-enyl bond, cis or trans, is not specified.


triacylglycerol 44:1

A triglyceride in which the three acyl groups contain a total of 44 carbons and 1 double bond.


A glycerolipid where one of the acyl groups is specified as (9Z)-octadec-9-en-12-ynoyl.


1-acylglycerol 20:3

A 1-monoglyceride in which the acyl group contains 20 carbons and 3 double bonds.


phosphatidylethanolamine 37:2

A phosphatidylethanolamine in which the two acyl groups contain a total of 37 carbons and 2 double bonds.


An N-glycosylated dialkylglycerophosphoethanolamine in which the alkyl groups are hexadecyl, the glycerol core has sn stereochemistry and the phosphoethanolamine unit is at position 3 and substituted on nitrogen with the branched nonasaccharide beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc.


A glycosylphosphatidylinositol compound consisting of D-mannopyranose joined to 1-phosphatidyl-1D-myo-inositol via an alpha-(1->2)-linkage.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as pentadecanoyl and docosanoyl respectively.


A glycerophosphoserine that is sn-glycero-3-phospho-L-serine in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, and in which the positions of the acyl and alkyl groups are also unspecified.


lysophosphatidylserine 16:2

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 16 carbons and 2 double bonds.


phosphatidylethanolamine 44:8

A phosphatidylethanolamine in which the two acyl groups contain a total of 44 carbons and 8 double bond.


phosphatidylinositol 37:4

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 37 carbon atoms and 4 double bonds.


phosphatidic acid 38:7

A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 5 double bonds.


A triacylglycerol 52:7 in which the acyl groups at positions 1, 2 and 3 are specified as tetradecanoyl, (9Z,12Z)-octadecadienoyl and (5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl respectively.


L-alpha-phosphatidylglycerol

A  phosphatidylglycerol that is an sn-glycerol 3-phosphate backbone ester-bonded to either saturated or unsaturated fatty acids on carbons 1 and 2. A further glycerol substituent is bonded via a phosphomonoester linkage.


A triacyl-sn-glycerol in which the 1-acyl group is tetradecanoyl while the 2- and 3-acyl groups are hexadecanoyl.


lysophosphatidylglycerol 17:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C17 chain and is attached to the glycero moiety at either position 1 or 2.


An inositol compound having alpha-mannosyl-alpha-glucosaminyl and phosphatidyl substituents on its hydroxy groups.


An alkylglycerol that is 1-palmityl-2-methyl-sn-glycerol carrying an additional oleoyl substituent at position 3.


A phosphatidylinositol 36:4 in which one acyl group has 16 carbons and is fully saturated while the other has 20 carbons and 4 double bonds (position not specified).


phosphatidyl-N-methylethanolamine

A phosphatidylethanolamine in which the amino group is methylated.


lysophosphatidylserine 15:0

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 15 carbons and 0 double bonds.


A monoglyceride in which the acyl group is located at position 3 with an additional alkyl substituent at position 1.


lysophosphatidic acid 17:0

A lysophosphatidic acid in which the acyl group (position not specified) contains 17 carbons and no double bonds.


A glycerophospholipid, where R1 and R2 are acyl chains and R3 any of the groups that represent the different phospholipid classes (choline, ethanolamine, glycerol, etc).


A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and myristoyl respectively.


A 1-O-(alk-1-enyl)-2-stearoyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl group has Z geochemistry.


phosphatidylserine O-18:0/0:0

A glycero-3-phosphoserine that is sn-glycero-3-phospho-L-serine substituted at position 1 by an octadecyl group.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and myristoyl.


triacylglycerol 49:2

A triglyceride in which the three acyl groups contain a total of 49 carbons and 2 double bonds.


phosphatidylinositol (18:1/20:4)

A 1-phosphatidyl-1D-myo-inositol in which one acyl group has 18 carbons and 1 double bond while the other has 20 carbons and 4 double bonds.


monoacylglycerol phosphate

Derivatives of phosphoglycerols which have only one of the alcohol groups of the glycerol backbone ester-linked with a fatty acid.


A 2-monoglyceride where the acyl group is decanoyl (caprinoyl).


triacylglycerol 53:3

A triglyceride in which the three acyl groups contain a total of 53 carbons and 3 double bonds.


A phosphatidylinositol mannoside having on a myo-inositol ring a phosphatidyl moiety (carrying palmitoyl and 10-methyloctadecanoyl groups) at the 1-position, an alpha-D-mannosyl residue at the 2-position, a palmitoyl group at the 5-position and a 6-O-palmitoyl-alpha-D-mannosyl group at the 6-position.


A triacylglycerol 46:0 in which the acyl groups at positions 1, 2 and 3 are specified as dodecanoyl, hexadecanoyl and octadecanoyl respectively.


Any glycerophospholipid consisting of sn-glycero-3-phosphoethanolamine in which one of the amino hydrogens is replaced by an acyl group.


lysophosphatidylserine 18:3

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 18 carbons and 3 double bonds.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as heptadecanoyl.


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


An acyl-sn-glycero-3-phosphate in which a single acyl substituent is located at position 2.


lysophosphatidylethanolamine 18:4

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 18 carbons and 4 double bonds.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecanoyl and docosatetraenoyl respectively.


A 1-acyl-sn-glycerol 2,3-cyclic phosphate having oleoyl as the 1-O-acyl group.


A 1-alkyl-2,3-diacylglycerol in which the alkyl group is specified as (9Z)-octadecenyl while the two acyl groups are both oleoyl.


A triacylglycerol 52:2 in which the acyl group at position 1 is specified as hexadecanoyl while those at positions 2 and 3 are both octadecenoyl groups.


An inositol compound having alpha-mannosyl-(1->6)-alpha-2-(2-aminoethylphosphoryl)mannosyl-beta-glucosaminyl and phosphatidyl substituents on its hydroxy groups.


phosphatidic acid 14:0

A phosphatidic acid in which the two acyl groups contain a total of 14 carbons and no double bonds.


triacylglycerol 55:3

A triglyceride in which the three acyl groups contain a total of 55 carbons and 3 double bonds.


A 1-O-alkyl-sn-glycerol in which the O-alkyl group is carrying a hydroxy substituent at position 1.


A triacylglycerol 53:4 in which the acyl groups at positions 1, 2 and 3 are specified as heptadecenoyl, octadecenoyl and octadecadienoyl respectively.


monobutyrin

A 1-monoglyceride resulting from the formal esterification of butyric acid with one of the primary hydroxy groups of glycerol. The R enantiomer is bioactive.


A triacylglycerol 42:1 in which the acyl groups at positions 1, 2 and 3 are specified as octanoyl, hexadecanoyl and octadecenoyl respectively.


A  3-acyl-sn-glycerol where alpha-linolenoyl is the 3-acyl group.


A 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is also hexadecanoyl.


A 1-O-alkyl-sn-glycerol that has octadec-9-en-1-yl as the alkyl group. The S enantiomer of selachyl alcohol.


A glycerol ether that is any 1-alkyl-3-acyl-sn-glycerol bearing an additional methyl substituent at position 2.


1-acylglycerol 18:2

A 1-monoglyceride in which the acyl group contains 18 carbons and 2 double bonds.


2-acylglycerol 20:5

A 2-monoglyceride in which the acyl group contains 20 carbons and 5 double bonds.


A CDP-diacylglycerol in which the acyl groups at positions 1 and 2 are specified as dodecanoyl.


A 1-phosphatidyl-1D-myo-inositol in which the two phosphatidyl acyl groups are specified as butanoyl.


CDP-diacylglycerol

A CDP-glycerol having unspecified acyl groups (most commonly fatty acyl groups) at the 1- and 2-positions.


phosphatidylglycerol 35:2

A phosphatidylglycerol in which the two acyl groups contain a total of 35 carbon atoms and 2 double bonds.


A 1-monoglyceride in which the glycerol moiety has (R)-configuration.


A  triacyl-sn-glycerol  in which the acyl groups at positions 1, 2 and 3 are specifed as palmitoyl, oleoyl and stearoyl respectively.


A phosphatidylinositol 5-phosphate in which the inositol moiety has configuration 1D-myo.


name: Glycerol 1-(9Z-octadecenoate) 2-tetradecanoate 3-phosphate


triacylglycerol 48:6

A triglyceride in which the three acyl groups contain a total of 48 carbons and 6 double bonds.


phosphatidylinositol 4-phosphate

A phosphatidylinositol monophosphate carrying the phosphate group at the 4-position.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which  acyl groups at positions 1 and 2 are specified as palmitoyl and arachidonoyl respectively.


monodecanoylglycerol

A monoglyceride in which the acyl group is decanoyl (capryl) with the position of acylation unspecified.


name: glycerol 1-monomycolate (C80) (Mycobacterium phlei)

description: A mycolate ester formed by esterification of (14E)-33-hydroxy-34-pentacosylpentatriacont-14-enedioic acid with the 1-OH of glycerol; produced by Mycobacterium phlei.


phosphatidylserine 40:9

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbons and 9 double bonds.


triradylglycerol

A glycerol compound having one of three possible substituent groups - either acyl, alkyl, or alk-1-enyl - at each of the three possible positions sn-1, sn-2 or sn-3. has functional parent glycerol (CHEBI:17754), children: triglyceride (CHEBI:17855). Parent: is_a glycerolipid (CHEBI:35741)


phosphatidylethanolamine (18:0/18:2)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 18 carbons and 2 double bonds.


A glycerophosphoglycerol having (R,S)-configuration.


lipophosphoglycan

A glycoconjugate expressed by Leishmania promastigotes, the stage of the parasite characteristic for the sandfly vector. Lipophosphoglycan consists of lysoalkyl-sn-glycerophosphoinositol linked to a phosphosaccharide core conserved in all species, which is connected to PO4-6Galbeta1,4Manalpha1 repeats with species-specific substitutions at the Gal residue; the repeats are capped by conserved and species-specific oligosaccharides.


dimethylphosphatidylethanolamine 32:0

A glycerophosphoethanolamine that is phosphatidylethanolamine 32:0 in which the two amino hydrogens have been replaced by methyl groups


phosphatidylethanolamine (18:1/22:0)

A phosphatidylethanolamine 40:1 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 22 carbons and no double bonds.


A 3-sn-phosphatidyl-L-serine in which the acyl substituents at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


phosphatidylethanolamine 42:9

A phosphatidylethanolamine in which the two acyl groups contain a total of 42 carbons and 9 double bonds.


triacylglycerol 43:4

A triglyceride in which the three acyl groups contain a total of 43 carbons and 4 double bonds.


A triacylglycerol 52:2 in which the acyl groups at positions 1 and 2 are specified as octadecenoyl, while that at position 3 is hexadecanoyl.


1-acylglycerol 22:6

A 1-monoglyceride in which the acyl group contains 22 carbons and 6 double bonds.


A triacylglycerol 51:4 in which the acyl groups at position is specified as pentadecenoyl while those at positions 2 and 3 are specified as octadecadienoyl.


A 1-alkyl-2-acyl-sn-glycero-3-phosphserine in which the alkyl and acyl groups are specified as (1Z)-octadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is also hexadecanoyl.


1,1'-dioleyl 2,2'-dilysocardiolipin

A 2,2'-dilyso cardiolipin in which both of the phosphatidyl acyl groups are specified as oleoyl.


A 1-(alk-1-enyl)-2-oleoyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl group has Z geochemistry.


phosphatidylserine 39:6

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 39 carbon atoms and 6 double bonds.


A triacylglycerol 62:11 in which the acyl groups at positions 1, 2 and 3 are specified as octadecenoyl, docosatetraenoyl and docosahexaenoyl respectively.


triacylglycerol 52:7

A triglyceride in which the three acyl groups contain a total of 52 carbons and 7 double bonds.


triacylglycerol 62:12

A triglyceride in which the three acyl groups contain a total of 62 carbons and 12 double bonds.


triacylglycerol 50:3

A triglyceride in which the three acyl groups contain a total of 50 carbons and 3 double bonds.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the phosphatidyl acyl groups at positions 1 and 2 are specified as icosanoyl and docosanoyl respectively.


triacylglycerol 54:2

A triglyceride in which the three acyl groups contain a total of 54 carbons and 2 double bonds.


A prenylglycerol phosphate that consists of 1-phosphoglycerol having two all-trans-pentaprenyl groups attached at position 2 and 3; major microspecies at pH 7.3.


phosphatidylethanolamine 20:4/18:1

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at C-1 and C-2 are eicosatetraenoyl (C20 straight-chain containing four C=C double bonds) and octadecenoyl (C18 straight-chain containing one C=C double bond) group respectively.


A 1-acyl-2-arachidonoyl-sn-glycero-3-phosphate(2-) in which the 1-acyl substituent is specified as heptadecanoyl


triacylglycerol 46:3

A triglyceride in which the three acyl groups contain a total of 46 carbons and 3 double bonds.


triacylglycerol 56:10

A triglyceride in which the three acyl groups contain a total of 56 carbons and 10 double bonds.


A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as hexadecanoyl (palmitoyl).


A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are stearoyl and (8Z,11Z,14Z)-eicosatrienoyl group respectively.


phosphatidylinositol (16:1/18:0)

A phosphatidylinositol 34:1 in which the acyl group at position 1 contains 16 carbons and 1 double bond while that at position 2 contains 18 carbons and no double bonds.


triacylglycerol 50:2

A triglyceride in which the three acyl groups contain a total of 50 carbons and 2 double bonds.


phosphatidylserine 36:1

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 36 carbon atoms and 1 double bond.


lysophosphatidylethanolamine 20:1

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and 1 double bond.


A CDP-diacylglycerol in which both phosphatidyl acyl groups are specified as oleoyl.


A member of the class of glycerophosphoglycerols that is sn-glycero-3-phospho-(1'-sn-glycerol) in which the hydroxy hydrogens at positions 1, 2 and 3' have been replaced by oleoyl groups.


A triacylglycerol 52:1 in which the acyl groups at positions 1, 2 and 3 are specified as oleoyl, isononadecanoyl and pentadecanoyl respectively. It is a metabolite of the nematode Caenorhabditis elegans.


phosphatidylinositol (16:0/18:3)

A phosphatidylinositol 34:3 in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 18 carbons and 3 double bonds


A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the acyl group is specified as oleoyl.


A 1-acyl-2-dodecanoyl-sn-glycerol-3-phosphate in which the 1-acyl group is also dodecanoyl (lauroyl).


phosphatidylethanolamine (18:1/22:6)

A phosphatidylethanolamine 40:7 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 22 carbons and 6 double bonds.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and tetradecanoyl respectively.


A 1-alkyl-2-acyl-sn-glycero-3-phosphserine in which the alkyl and acyl groups are specified as (1Z)-octadecenyl and arachidonoyl respectively.


lysophosphatidylinositol 20:4

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 20 carbons and 4 double bonds.


lysophosphatidylinositol 16:0

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.


dioleoyl phosphatidylethanolamine

A phosphatidylethanolamine in which the phosphatidyl acyl groups are both oleoyl.


A 1-acyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the acyl group is specified as tetradecanoyl (myristoyl)


A glycerolipid where one of the acyl groups is specified as (11Z,14Z)-icosadienoyl.


A glycerolipid where one of the acyl groups is specified as (5Z,9Z,12Z,15Z)-octadecatetraenoyl.


A CDP-glycerol that is 2,3-bis-O-(phytanyl)-sn-glycerol (archaeol) having a CDP moiety attached at position 1.


A phosphatidylglycerol consisting of cardiolipin lacking one fatty acyl group from the 2 or 2'-position.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as myristoyl (tetradecanoyl) while the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl).


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituent both at positions 1 and 2 is specified as (6Z,9Z)-octadecadienoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as docosanoyl and tetradecanoyl respectively.


triacylglycerol 30:0

A triglyceride in which the three acyl groups contain a total of 30 carbons and no double bonds.


phosphatidylethanolamine (18:0/18:3)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 18 carbons and 3 double bonds.


lysophosphatidylglycerol 16:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C16 chain and is attached to the glycero moiety at either position 1 or 2.


A 1-O-acyl-sn-glycero-3-phosphate in which the acyl group is specified as caproyl (hexanoyl).


A triacylglycerol 58:5 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, icosenoyl and icosatetraenoyl respectively.


A 1-alkyl-3-acylglycerol in which the glycerol moiety has sn stereochemistry.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and stearoyl.


phosphatidylserine 16:0/18:1

A phosphatidylserine 34:1 in which the 1-acyl group contains 16 carbons and no double bonds while the 2-acyl group contains 18 carbons and one double bond.


triacylglycerol 48:2

A triglyceride in which the three acyl groups contain a total of 48 carbons and 2 double bonds.


triacylglycerol 58:8

A triglyceride in which the three acyl groups contain a total of 58 carbons and 8 double bonds.


triacylglycerol 56:4

A triglyceride in which the three acyl groups contain a total of 56 carbons and 4 double bonds.


glycerophosphoinositol monophosphate

Any glycerophosphoinositol bearing one phospho substituent on the inositol ring.


A 1-acyl-2-octadecanoyl-sn-glycerol-3-phosphate in which the 1-acyl group is also octadecanoyl.


An alkyl,acyl-sn-glycero-3-phosphoserine in which unspecified acyl and alkyl groups are located at positions 1 and 2 respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as octadecenoyl and octadecadienoyl respectively.


A 1-acyl-sn-glycero 3-phospho-(1'-sn-glycerol) in which the acyl group is specified as 9Z-octadecenoyl.


phosphatidyl-N,N-dimethylethanolamine

A phosphatidylethanolamine in which the amino group is dimethylated.


monomethylphosphatidylethanolamine 36:2

A glycerophosphoethanolamine that is phosphatidylethanolamine 32:0 in which one of the amino hydrogens has been replaced by a methyl group.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively.


phosphatidylinositol 36:2

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 36 carbon atoms and 2 double bonds.


A glycerolipid where one of the acyl groups is specified as (6Z,9Z,12Z,15Z)-octadecatetraenoyl.


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and palmitoleoyl respectively.


A monoacylglycerol 16:1 in which the acyl group specified at position 2 is 9Z)-hexadecenoyl.


1-acylglycerol 22:5

A 1-monoglyceride in which the acyl group contains 22 carbons and 5 double bonds.


phosphatidylserine 40:7

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 7 double bonds.


monoacylglycerol 18:2

A monoglyceride in which the acyl groups contain a total of 18 carbons and two double bonds.


lysophosphatidylserine 22:5

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 22 carbons and 5 double bonds.


1-linoleoyl-sn-glycerol 3-phosphate

A 1-acyl-sn-glycerol 3-phosphate having linoleyl (9Z,12Z-octadecadienoyl) as the 1-O-acyl group.


A 2-acylglycerophosphoinositol in which sn-glycerol, acylated at O(2), is linked through a phospho group at O(3) to O(1) of D-myo-inositol.


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and arachidonoyl respectively.


A phosphatidylethanolamine 36:4 in which one acyl group has 16 carbons and is fully saturated while the other has 20 carbons and 4 double bonds (position not specified).


monoacylglycerol 20:4

A monoglyceride in which the acyl group contains a total of 20 carbon atoms and 4 double bonds.


glyceride

Any ester resulting from the condensation of one or more of the hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids.


name: 9-Octadecenoic acid 1-[[(1-oxohexadecyl)oxy]methyl]-2-(phosphonoxy)ethyl ester


Any glycerolipid in which the acyl group at position 2 of the glycerol moiety is specified as (3E)-hexadec-3-enoyl.


An N-oleoylphosphatidylethanolamine in which the acyl groups at positions 1 and 2 are both specified as heptadecanoyl.


A 1-[(Z)-alk-1-enyl]-sn-glycero-3-phospho-(N-acyl)ethanolamine in which the alk-1-enyl and N-acyl groups are specified as 1Z-octadecenyl and arachidonoyl respectively.


An aminoxyl (nitroxide) free radical dipalmitoyl glycerophosphoethanolamine derivative used as a hapten in immunological investigations.


lysophosphatidylserine 16:1

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 16 carbons and 1 double bond.


A CDP-diacylglycerol in which both phosphatidyl acyl groups are specified as linoleoyl.


A phosphatidic acid in which the acyl groups at positions 1 and 2 are specifed as stearoyl and arachidonoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as stearoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A triacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specified as (11Z)-icosenoyl.


A 1-(alk-1-enyl)-sn-glycero-3-phosphoethanolamine zwitterion in which the alkenyl group has Z geochemistry.


PHOSPHATIDYL SERINE

A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl group at both positions 1 and 2 is stearoyl.


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as stearoyl (octadecanoyl).


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 11Z-octadecenoyl respectively.


A alk-1-enylacylglycerol having the alk-1-enyl substituent in the sn-1 or sn-3 position and an acyl substituent in the sn-2 position. The orientation of the alk-1-enyl bond, cis or trans, is not specified.


A 3-acyl-sn-glycerol that is the R-enantiomer of 2,3-dihydroxypropyl decanoate.


A 1-acyl-2-arachidonoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as icosanoyl (arachidoyl).


An N-glycosylated dialkylglycerophosphoethanolamine in which the dialkylglycerophosphoethanolamine is 1,2-dihexadecyl-sn-glycero-3-phosphoethanolamine and the glycosylating saccharide is the branched decasaccharide alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc, the GlcNAc residue at the reducing end of which is in the ring-opened form.


reduced cardiolipin

A reduced form of cardiolipin, usually arising from hydrogenation of any C=C double bonds in the phosphatidyl acyl groups.


The N-[(p-azobenzenearsonic acid)-L-tyrosyl] derivative of phosphatidylethanolamine.


A glycerophosphoglycerol where both glycerol moieties are attached at primary positions and one stereocentre has R-configuration.


acetyl cardiolipin

A derivative of cardiolipin having an acetyl group attached to the free hydroxy group of the central glycerol moiety.


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which both phosphatidyl acyl groups are specified as butanoyl.


A 2-monoglyceride where the acyl group is (9Z,12Z,15Z)-octadecatrienoyl (alpha-linolenoyl).


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecanoyl and octadecenoyl respectively.


A triacyl-sn-glycerol in which the which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, (9Z)-octadecenoyl and (11Z)-icosenoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as octadecanoyl and (9Z)-hexadecenoyl respectively.


phosphatidylserine 36:4

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 36 carbon atoms and 4 double bonds.


phosphatidylinositol 36:3

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 36 carbon atoms and 3 double bonds.


phosphatidylglycerol 42:0

A phosphatidylglycerol in which the two acyl group contain a total of 42 carbon atoms and no double bonds


triacylglycerol 42:1

A triglyceride in which the three acyl groups contain a total of 42 carbons and 1 double bond.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as octadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


phosphatidylglycerol 34:1

A phosphatidylglycerol in which the two acyl groups contain a total of 34 carbon atoms and 1 double bond.


An N-glycosylated dialkylglycerophosphoethanolamine in which the alkyl groups are hexadecyl, the glycerol core has sn stereochemistry and the phosphoethanolamine unit is at position 3 and substituted on nitrogen with the branched undecasaccharide alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc.


alkyldiacylglyceride

A triradylglycerol with a single alkyl substituent and two acyl substituents at unspecified positions.


A phosphatidylglycerol 12:0 in which the acyl groups at C-1 and C-2 are both hexanoyl.


triacylglycerol 50:0

A triglyceride in which the three acyl groups contain a total of 50 carbons and 0 double bonds.


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as octadecanoyl (stearoyl).


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as (9E)-octadecenoyl.


A 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate in which both phosphatidyl acyl groups are specified as octanoyl


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as (5Z,8Z,11Z,14Z)-icosatetraenoyl (arachidonyl).


1-acylglycerol 20:5

A 1-monoglyceride in which the acyl group contains 20 carbons and 5 double bonds.


triacylglycerol 56:9

A triglyceride in which the three acyl groups contain a total of 56 carbons and 9 double bonds.


A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as oleoyl.


tetrastearoyl cardiolipin

A cardiolipin derivative in which all four of the phosphatidyl acyl groups are specified as stearoyl (octadecanoyl).


phosphatidylserine 42:1

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 42 carbon atoms and 1 double bond.


glycerophosphoinositol phosphate

Any glycerophosphoinositol bearing one or more additional phospho substituents on the inositol ring.


A phosphatidylinositol mannoside consisting of two alpha-D-mannopyranose residues attached at positions 2 and 6 of 1-phosphatidyl-1D-myo-inositol via glycosidic linkages.


triacylglycerol 54:7

A triglyceride in which the three acyl groups contain a total of 54 carbons and 7 double bonds.


A triacylglycerol 50:7  in which the acyl groups at positions 1, 2 and 3 are specified as dodecanoyl, (9Z,12Z)-octadecadienoyl and (5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are both (9Z)-hexadecenoyl (palmitoleoyl).


A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl groups are both oleoyl.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as icosanoyl (arachidoyl) and hexadecanoyl (palmitoyl) respectively.


A CDP-diacylglycerol in which the acyl groups at positions 1 and 2 are specified as octadec-11-enoyl.


A glycerolipid where one of the acyl groups is specified as (9Z,12Z)-octadeca-9,12-dien-6-ynoyl.


A 1-monoglyceride resulting from the formal condensation of the carboxy group of icosanoic acid with one of the primary hydroxy groups of glycerol.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups specified at position 1 and 2 are palmitoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


1-acyl-2-arachidonoyl-sn-glycero-3-phospho-D-myo-inositol in which the 1-acyl group is specified as (10Z)-heptadecenoyl.


A triacylglycerol 62:13 in which the acyl groups at positions 1 and 2 are specified as icosatetraenoyl while that at position 3 is a docosahexaenoyl group.


dimyristoyl phosphatidic acid

A phosphatidic acid in which the phosphatidyl acyl groups are both myristoyl.


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


A  triacyl-sn-glycerol in which the acyl groups at positions 1, 2 and 3 are specified as oleoyl, linoleoyl and linoleoyl respectively.


lysophosphatidylinositol 17:0

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 17 carbons and 0 double bonds.


1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as heptanoyl and hexanoyl respectively.


A glycerophosphoinositol that is any sn-glycero-3-phospho-1D-myo-inositol in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, and in which the positions of the acyl and alkyl groups are also unspecified.


triacylglycerol 44:0

A triglyceride in which the three acyl groups contain a total of 44 carbons and 0 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as arachidonoyl


A phosphatidylethanolamine 38:3 in which one acyl group has 18 carbons and 2 double bonds while the other has 20 carbons and 1 double bond (position not specified).


monoacylglycerol 22:6

A monoglyceride in which the acyl group contains a total of 22 carbon atoms and 6 double bonds.


The 2,3-bis-O-(geranylgeranyl)- derivative of sn-glycerol 1-phosphate.


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A glycerophosphoinositol that is 1-D-myo-inositol substituted at position 1 by an archaetidyl group.


A glycerolipid where one of the acyl groups is specified as (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl.


A phosphatidylsulfocholine in which the hydroxyl group of sulfocholine is esterified to the phosphate group of phosphatidic acid.


An N-acyl-O-(3-sn-phosphatidyl)-L-serine obtained by formal condensation of the carboxy group of hexadecanoic acid with the amino group of 1-octadecanoyl-sn-glycero-3-phospho-L-serine


tetraoleyl cardiolipin

A cardiolipin derivative in which all four of the phosphatidyl acyl groups are specified as oleoyl.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as octadecanoyl (stearoyl) and hexadecanoyl (palmitoyl) respectively.


A 1-phosphatidyl-1D-myo-inositol 4-phosphate  in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


phosphatidylinositol (16:1/18:1)

A phosphatidylinositol 34:2 in which the acyl group at position 1 contains 16 carbons and 1 double bond while that at position 2 contains 18 carbons and 1 double bond.


phosphatidylethanolamine 38:7

A phosphatidylethanolamine in which the two acyl groups contain a total of 38 carbons and 7 double bonds.


A 1-alkyl-2-acyl-sn-glycero-3-phosphate in which the 1-alkyl substituent can be any alk-1-enyl group.


Any glycerolipid where the 1-acyl group is specified as oleoyl.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as (9Z)-octadecenoyl and (9Z)-hexadecenoyl respectively.


An N-acyl-sn-glycero-3-phosphoethanolamine in which the N-acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


phosphatidylglycerol (16:0/17:1)

A phosphatidylglycerol 33:1 in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 17 carbons and 1 double bond.


triacylglycerol 46:4

A triglyceride in which the three acyl groups contain a total of 46 carbons and 4 double bonds.


phosphatidylglycerol (18:2/16:1)

A phosphatidylglycerol 34:3 in which the acyl group at position 1 contains 18 carbons and two double bonds while that at position 2 contains 16 carbons and 1 double bond.


lysophosphatidylserine 17:1

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 17 carbons and 1 double bond.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as arachidonoyl while the phosphatidyl acyl groups are both specified as oleoyl.